33 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
2 Unknown  Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
3 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
4 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
5 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
6 Recruiting Ticagrelor and Endothelial Function
Condition: Antiplatelet Agents; Endothelial Function; Pleotropic Effects
Interventions: Drug: ticagrelor;   Drug: prasugrel
7 Recruiting Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Conditions: Cerebral Hemorrhage;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
8 Unknown  BLeeding Events and Maintenance DoSe of PraSugrel
Conditions: Adverse Reaction to Antiplatelet Agent;   Acute Coronary Syndrome
Interventions: Drug: Prasugrel dose 5 mg/day;   Drug: Prasugrel dose 10 mg/day
9 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
10 Unknown  Platelet Transfusion in Acute Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Intervention: Biological: platelets
11 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
12 Recruiting Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
Condition: Angina Pectoris
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
13 Unknown  Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel;   Drug: Prasugrel
14 Unknown  Platelet Function in Patients With an Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Intervention:
15 Recruiting Pharmacodynamic Study of Cilostazol in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Cilostazol;   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
16 Not yet recruiting Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: ticagrelor
17 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
18 Recruiting ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
Condition: Coronary Artery Disease
Interventions: Drug: 1-month DAPT;   Drug: 12-month DAPT
19 Not yet recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
20 Recruiting Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years